References

  1. Pavlides, , et al. (2017). Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver International, 37(7), 1065-1073. https://doi.org/10.1111/liv.13284

 

  1. Imajo, K., et al. (2021). Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort. World Journal of Gastroenterology, 27(7), 609–623. https://doi.org/10.3748/wjg.v27.i7.609

 

  1. Dennis, A., et al. (2021). Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis. Frontiers in Endocrinology, 11, 575843. https://www.frontiersin.org/articles/10.3389/fendo.2020.575843

 

  1. Dennis, A., et al. (2020). A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis. Scientific Reports, 10(1), 15308.  https://doi.org/10.1038/s41598-020-71995-8

 

  1. Andersson, A., et al. (2021). Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis. Clinical Gastroenterology and Hepatology. Advance online publication. https://doi.org/10.1016/j.cgh.2021.09.041

 

  1. Banerjee, R., et al. (2014). Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. Journal of Hepatology, 60(1), 69-77. https://doi.org/10.1016/j.jhep.2013.09.002

 

  1. McDonald, N., et al. (2018). Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Scientific Reports, 8(9187), 1-10. https://doi.org/10.1038/s41598-018-27560-5

 

  1. Eddowes, P., et al. (2017). Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 47(5), 631- 644. https://doi.org/10.1111/apt.14469

 

  1. Pavlides, M., et al. (2017). Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver International, 37(7), 1065-1073. https://doi.org/10.1111/liv.13284

 

  1. Jayaswal, A., et al. (2020). Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. Liver International, 40(12), 3071-3082. https://doi.org/10.1111/liv.14625

 

  1. Bachtiar, V., et al. (2019). Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS One, 14(4), e0214921. https://doi.org/10.1371/journal.pone.0214921

 

  1. Mozes, F. (2019). Magnetic resonance imaging of the liver. T1 dynamics: confounders and modelling [PhD thesis]. University of Oxford.

 

  1. Reeder, et al. (2011). Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. Journal of magnetic resonance imaging: JMRI34(4), 729–749. https://doi.org/10.1002/jmri.22775